Xu Shihao, Spencer Cody M, Munger Joshua
Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA.
Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA
J Virol. 2015 Jun;89(12):6406-17. doi: 10.1128/JVI.03671-14. Epub 2015 Apr 8.
Oncogenesis is frequently accompanied by the activation of specific metabolic pathways. One such pathway is fatty acid biosynthesis, whose induction is observed upon transformation of a wide variety of cell types. Here, we explored how defined oncogenic alleles, specifically the simian virus 40 (SV40) T antigens and oncogenic Ras(12V), affect fatty acid metabolism. Our results indicate that SV40/Ras(12V)-mediated transformation of fibroblasts induces fatty acid biosynthesis in the absence of significant changes in the concentration of fatty acid biosynthetic enzymes. This oncogene-induced activation of fatty acid biosynthesis was found to be mammalian target of rapamycin (mTOR) dependent, as it was attenuated by rapamycin treatment. Furthermore, SV40/Ras(12V)-mediated transformation induced sensitivity to treatment with fatty acid biosynthetic inhibitors. Pharmaceutical inhibition of acetyl-coenzyme A (CoA) carboxylase (ACC), a key fatty acid biosynthetic enzyme, induced caspase-dependent cell death in oncogene-transduced cells. In contrast, isogenic nontransformed cells were resistant to fatty acid biosynthetic inhibition. This oncogene-induced sensitivity to fatty acid biosynthetic inhibition was independent of the cells' growth rates and could be attenuated by supplementing the medium with unsaturated fatty acids. Both the activation of fatty acid biosynthesis and the sensitivity to fatty acid biosynthetic inhibition could be conveyed to nontransformed breast epithelial cells through transduction with oncogenic Ras(12V). Similar to what was observed in the transformed fibroblasts, the Ras(12V)-induced sensitivity to fatty acid biosynthetic inhibition was independent of the proliferative status and could be attenuated by supplementing the medium with unsaturated fatty acids. Combined, our results indicate that specific oncogenic alleles can directly confer sensitivity to inhibitors of fatty acid biosynthesis.
Viral oncoproteins and cellular mutations drive the transformation of normal cells to the cancerous state. These oncogenic alterations induce metabolic changes and dependencies that can be targeted to kill cancerous cells. Here, we find that the cellular transformation resulting from combined expression of the SV40 early region with an oncogenic Ras allele is sufficient to induce cellular susceptibility to fatty acid biosynthetic inhibition. Inhibition of fatty acid biosynthesis in these cells resulted in programmed cell death, which could be rescued by supplementing the medium with nonsaturated fatty acids. Similar results were observed with the expression of oncogenic Ras in nontransformed breast epithelial cells. Combined, our results suggest that specific oncogenic alleles induce metabolic dependencies that can be exploited to selectively kill cancerous cells.
肿瘤发生常常伴随着特定代谢途径的激活。其中一条途径是脂肪酸生物合成,在多种细胞类型发生转化时都可观察到其诱导现象。在此,我们探究了特定的致癌等位基因,特别是猿猴病毒40(SV40)T抗原和致癌性Ras(12V),如何影响脂肪酸代谢。我们的结果表明,SV40/Ras(12V)介导的成纤维细胞转化在脂肪酸生物合成酶浓度无显著变化的情况下诱导了脂肪酸生物合成。这种致癌基因诱导的脂肪酸生物合成激活被发现是哺乳动物雷帕霉素靶蛋白(mTOR)依赖性的,因为它会被雷帕霉素处理所减弱。此外,SV40/Ras(12V)介导的转化诱导了对脂肪酸生物合成抑制剂治疗的敏感性。对关键脂肪酸生物合成酶乙酰辅酶A(CoA)羧化酶(ACC)的药物抑制在致癌基因转导的细胞中诱导了半胱天冬酶依赖性细胞死亡。相比之下,同基因未转化细胞对脂肪酸生物合成抑制具有抗性。这种致癌基因诱导的对脂肪酸生物合成抑制的敏感性与细胞的生长速率无关,并且可以通过在培养基中补充不饱和脂肪酸来减弱。脂肪酸生物合成的激活和对脂肪酸生物合成抑制的敏感性都可以通过致癌性Ras(12V)转导传递给未转化的乳腺上皮细胞。与在转化的成纤维细胞中观察到的情况类似,Ras(12V)诱导的对脂肪酸生物合成抑制的敏感性与增殖状态无关,并且可以通过在培养基中补充不饱和脂肪酸来减弱。综合来看,我们的结果表明特定的致癌等位基因可以直接赋予对脂肪酸生物合成抑制剂的敏感性。
病毒癌蛋白和细胞突变驱动正常细胞向癌状态转化。这些致癌改变诱导代谢变化和依赖性,可将其作为靶点来杀死癌细胞。在此,我们发现SV40早期区域与致癌性Ras等位基因联合表达导致的细胞转化足以诱导细胞对脂肪酸生物合成抑制的敏感性。在这些细胞中抑制脂肪酸生物合成导致程序性细胞死亡,通过在培养基中补充不饱和脂肪酸可以挽救这种死亡。在未转化的乳腺上皮细胞中表达致癌性Ras时也观察到了类似结果。综合来看,我们的结果表明特定的致癌等位基因诱导代谢依赖性,可利用这些依赖性来选择性地杀死癌细胞。